CeriBell, Inc. (NASDAQ:CBLL) Q4 2025 Earnings Call Transcript
Operator: Hello, and welcome to the CeriBell, Inc. Q4 2025 Earnings Call. All lines have been placed on mute to prevent any background noise.
Ceribell Inc. (CBLL)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Royce & Associates Chuck Royce | 533,300 | $11,695,269 | 0.12% | |
| 2. | Adage Capital Management Phill Gross And Robert Atchinson | 500,000 | $10,965,000 | 0.02% | |
| 3. | Redmile Group Jeremy Green | 435,239 | $9,544,791 | 0.7% | |
| 4. | Two Sigma Advisors John Overdeck And David Siegel | 235,900 | $5,173,287 | +12% | 0.01% |
| 5. | Millennium Management Israel Englander | 198,701 | $4,357,513 | -71% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $17.00 | 380,268 | $6,464,556.00 | 3,967,422 | 2024-10-15 | Filing | |
| $17.00 | 237,234 | $4,032,978.00 | 2,475,110 | 2024-10-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $19.98 | 781 | $15,604.38 | 17,550 | 2026-02-24 | Filing | |
| $19.79 | 569 | $11,260.51 | 18,331 | 2026-02-23 | Filing | |
| $19.79 | 768 | $15,198.72 | 26,933 | 2026-02-23 | Filing | |
| $19.79 | 705 | $13,951.95 | 166,912 | 2026-02-23 | Filing | |
| $19.79 | 808 | $15,990.32 | 118,334 | 2026-02-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,967,422 | $87,005,564 | 3.24% | |
| 2. | 3,928,666 | $86,155,651 | 0% | |
| 3. | 2,205,661 | $48,370,146 | 44.37% | |
| 4. | 1,848,410 | $40,535,631 | 0% | |
| 5. | 1,507,909 | $33,068,445 | 0% |
News See All
CeriBell, Inc. (NASDAQ:CBLL) Q3 2025 Earnings Call Transcript
Operator: Good afternoon, and thank you all for participating in today's call.
J.P. Morgan Maintains a Buy Rating on CeriBell (CBLL) With a $21 PT
CeriBell, Inc. (NASDAQ:CBLL) is one of the best medical device stocks to buy according to analysts. J.P. Morgan analyst Robbie Marcus maintained a Buy rating on CeriBell, Inc.
12 Best Medical Device Stocks to Buy According to Analysts
On July 7, CNBC’s Chery Kang and Elaine Yu talked about China’s imposition of reciprocal tariffs on the import of medical devices from the European Union.
CeriBell, Inc. (NASDAQ:CBLL) Q2 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. My name is [ Desiree ], and I will be your conference operator today.
Transforming Neurological Care: Ceribell (CBLL)
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” first-quarter 2025 investor letter.
CeriBell, Inc. (NASDAQ:CBLL) Q1 2025 Earnings Call Transcript
Operator: Hello, and thank you for standing by. At this time, I would like to welcome you to the CeriBell, Inc. Q1 2025 Earnings Call.
CeriBell, Inc. (NASDAQ:CBLL) Q4 2024 Earnings Call Transcript
Operator: Operator Hello, and thank you for standing by. At this time, I would like to welcome you to the CeriBell Q4 2024 Earnings Call.
Hedge Fund Resource Center